Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells
Your new post is loading...
Your new post is loading...
Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells No comment yet.
Sign up to comment
BigField GEG Tech's insight:
Six months after gene delivery using LV which express sulphamidase and SUMF1, bladder distension was prevented in all treated animals, and behavioural deficits were improved. The levels of ganglioside and lysosomal β-hexosaminidase, both of which are characteristically elevated in MPS IIIA, were significantly reduced, or were normalised.
BigField GEG Tech's insight:
In the present work, three lentiviral vectors were constructed for the human growth hormone (GH), interleukin 2 (IL2), and granulocyte colony-stimulating factor 3 (CSF3) genes driven by the bovine β-casein promoter. The results suggest that MAC-T cells may be a good system to evaluate vector construction targeting recombinant protein expression in milk.
Molecular Therapy — Methods & Clinical Development, Published online: 8 January 2014; | doi:10.1038/mtm.2013.2
BigField GEG Tech's insight:
The authors describe the selection and characterization of the K42E gain-of-function mutation in IN, which greatly improves the efficiency of this system. Both K42E and initial reverse-charge mutations in IN negatively affected reverse transcription and integration, yet when combined together boosted viral transduction efficiency to ~75% of the wild-type vector in a manner dependent on a complementary LEDGF/p75 variant. They conclude that the specificity of lentiviral retargeting strategies based on heterologous LEDGF/p75 fusion proteins will benefit from our optimized system that utilizes the unique complementation properties of reverse-charge IN mutant viral and LEDGF/p75 host proteins.
BigField GEG Tech's insight:
The results indicate that myostatin-targeting siRNA expressed by a lentiviral vectors could efficiently down-regulate myostatin expression. Therefore, targeted knock down of the MSTN gene using lentivirus-mediated shRNA transgenics would facilitate customized cell engineering, allowing potential use in the establishment of stable cell lines to produce genetically engineered animals
BigField GEG Tech's insight:
The authors injected an AAV8-F9 vector into neonatal and adult mice and achieved on-target integration into ~0.5% of the albumin alleles in hepatocytes They demonstrated that transgene integration as a 2A-fusion to a highly expressed endogenous gene may obviate the requirement for nucleases and/or vector-borne promoters.
BigField GEG Tech's insight:
This video explains how three lines of LentiVectors display different expression patterns. These three line constitute a "toolbox" for gene transfer. This video allows to find the best version of LentiVectors according the project.
BigField GEG Tech's insight:
Thanks to lentiviral vectors, the authors designed a strategy for human ESCs and iPSCs can be converted into functional iN cells with nearly 100% yield and purity in less than 2 weeks by forced expression of a single transcription factor. The resulting ES-iN or iPS-iN cells exhibit quantitatively reproducible properties independent of the cell line of origin, form mature pre- and postsynaptic specializations, and integrate into existing synaptic networks when transplanted into mouse brain. http://geg-tech.com/services.html
BigField GEG Tech's insight:
The authors show that coexpression of miR-9/9∗-124, thanks to lentiviral vectors, with transcription factors enriched in the developing striatum, BCL11B (also known as CTIP2), DLX1, DLX2, and MYT1L, can guide the conversion of human postnatal and adult fibroblasts into an enriched population of neurons analogous to striatal medium spiny neurons (MSNs). When transplanted in the mouse brain, the reprogrammed human cells persisted in situ for over 6 months, exhibited membrane properties equivalent to native MSNs, and extended projections to the anatomical targets of MSNs. http://geg-tech.com/services.html
BigField GEG Tech's insight:
In this study, the authors showed that an expression system involving a lentiviral vector that carries the human metallothionein gene basal promoter ensures stable and basal-level expression of proteins and is thus suitable for investigating the properties of lamin A mutants. The small ubiquitin-related modifier (SUMO) modification (SUMOylation)-defective E203G mutant that is associated with familial dilated cardiomyopathy exhibited abnormal subnuclear distribution and inhibited normal localization of WT lamin A in a dominant-negative manner. Their results indicate that the E203G mutant may inhibit the normal functions of wild-type lamin A in a dominant-negative manner, but a defect in SUMOylation itself may not be involved in disease pathogenesis. http://geg-tech.com/services/on-demand-priority-program.html
BigField GEG Tech's insight:
This video explains how the choice of the right envelope for your lentiviral vector can influence your experiment.
BigField GEG Tech's insight:
This review offers a starting point for those new to lentiviral-based vector systems, addressing the main issues involved with the use of lentiviral systems in vitro and outlines considerations which should be taken into account during experimental design.
Molecular Therapy — Nucleic Acids is a new international all open-access journal publishing top-quality basic, translational and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease.
BigField GEG Tech's insight:
The authors used non-integrating lentivirus (NILV) for transient expression of ZFNs and pseudotyped the virus with HIV-envelope for targeted delivery to CD4+ T cells. Both activated and resting primary CD4+ T cells transduced with CCR5-ZFNs NILV showed resistance to HIV-1 infection in vitro. GEG-tech offers a large choice in Non Integrating Lentiviral Vectors http://geg-tech.com/products/vectors.html?gamme=Lenti-ONE%E2%84%A2+Epi |
BigField GEG Tech's insight:
In this study, two variants, LCMV-WE and LCMV-Arm53b, were evaluated for their ability to mediate LV-based cellular transduction in vitro. In contrast to LCMV-Arm53b, we found that, in mice, LCMV-WE-bearing LVs encoding a model antigen, invariant chain ovalbumin (Ii-OVA), could elicit substantial antigen-specific CD8+ T cell immune response. The response could be further enhanced by a homologous boosting immunization with the same vector. These findings offer evidence to support the potential utilization of LCMV-WE-bearing LVs for vectored vaccines against cancer and infectious diseases.
BigField GEG Tech's insight:
In this study, scientists describe a qPCR-based approach for estimation of lentiviral vector titer (pLV-THM-GFP). This approach provides researchers with a tool to perform low-cost assessment with highly repeatable results.
BigField GEG Tech's insight:
The authors created genetic engineered mesenchymal stem cell mediating with lentiviral vectors for releasing IL-27 as a good vehicle ex-vivo gene therapy for reduction of inflammation and autoimmune diseases.
BigField GEG Tech's insight:
The scientists designed a lentiviral vector in which the GFP expression was driven by the oligodendrocyte specific 2,3-cyclic nucleotide 3-phosphodiesterase (CNP) promoter. Assessment of EGFP expression revealed a widespread distribution specifically in cells of the oligodendrocyte linage, starting from postnatal day 6 (P6). By P30 it was detectable throughout the brain and persisted for at least 3 months showing an increase both in the number of expressing cells and in intensity over time. In conclusion, lentiviral gene delivery using CNP promoter may achieve widespread and long lasting expression selectively in oligodendrocytes.
BigField GEG Tech's insight:
This study shows that overexpression of gigaxonin either using a lentiviral vector or as a stable transgene resulted in normalization of neurofilament and peripherin proteinlevels in GAN neurons and disappearance of PRPH aggregates without adverse effect on survival of GAN neurons.
BigField GEG Tech's insight:
Scientists used intranigral or intrastriatal lentiviral vector-mediated expression to evaluate their efficacy at protecting dopaminergic function in the 6-OHDA model of Parkinson’s disease (PD). They conclude that nigral CDNF and MANF delivery is more efficacious than striatal delivery. The results also suggest that multiple neurotrophic factors (NTFs) delivery may be more efficacious for the treatment of PD than the single NTF approaches attempted so far.
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.
BigField GEG Tech's insight:
BigField GEG Tech's insight:
In this study, the researchers conclued that direct gene transfer with lentivirale vectors into CD133+ cells allows for sustained long-term engraftment of gene corrected cells.
Original Article from The New England Journal of Medicine — Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
BigField GEG Tech's insight:
Relapsed acute lymphoblastic leukemia (ALL) is difficult to treat despite the availability of aggressive therapies. Chimeric antigen receptor–modified T cells targeting CD19 may overcome many limitations of conventional therapies and induce remission in patients with refractory disease.
CRISPR-Cas9 can be used to edit both single and multiple genes in postmitotic neurons in adult mice enabling rapid assessment of gene functions in the brain.
BigField GEG Tech's insight:
The authors demonstrate that AAV-mediated SpCas9 genome editing can enable reverse genetic studies of gene function in the brain.
BigField GEG Tech's insight:
In this Becker muscular dystrophy proof-of-principle clinical trial, a potent myostatin antagonist, follistatin (FS), was used to inhibit the myostatin pathway. The authors showed that histological changes corroborated benefit showing reduced endomysial fibrosis, reduced central nucleation, more normal fiber size distribution with muscle hypertrophy, especially at high dose.
BigField GEG Tech's insight:
The authors showed that pharmacological stimulation of A2A receptors or injection of lentiviral vectors expressing the A2A receptor into white fat induces brown-like cells. Importantly, mice fed a high-fat diet and treated with an A2A agonist are leaner with improved glucose tolerance. These results demonstrate that adenosine–A2A signalling plays an unexpected physiological role in sympathetic BAT activation and protects mice from diet-induced obesity. Those findings reveal new possibilities for developing novel obesity therapies. |
Your new post is loading...
In this study, using an improved method for in vivo conversion of adult mouse pancreatic acinar cells toward beta cells, the authors show that induced beta cells persist for up to 13 months (the length of the experiment), form pancreatic islet–like structures and support normoglycemia in diabetic mice.
http://geg-tech.com